Of mice and men: converging on a common molecular understanding of osteoarthritis

TL Vincent - The Lancet Rheumatology, 2020 - thelancet.com
Despite an increasing burden of osteoarthritis in developed societies, target discovery has
been slow and there are currently no approved disease-modifying osteoarthritis drugs. This …

Gene expression signatures of synovial fluid multipotent stromal cells in advanced knee osteoarthritis and following knee joint distraction

C Sanjurjo-Rodriguez, A Altaie… - … in bioengineering and …, 2020 - frontiersin.org
Osteoarthritis (OA) is the most common musculoskeletal disorder. Although joint
replacement remains the standard of care for knee OA patients, knee joint distraction (KJD) …

Using synovial fluid biomarkers to define a phenotype of osteoarthritis in the hip

JAJ Broomfield - 2020 - ora.ox.ac.uk
Osteoarthritis (OA) is a chronic, multi-factorial, progressive joint disease. The understanding
of OA has evolved away from a wear and tear phenomenon to a complex disease of the joint …

Post-traumatic OA (PTOA): what have we learned to advance osteoarthritis?

F Watt - Current Opinion in Rheumatology, 2020 - ora.ox.ac.uk
Purpose of review: Current thinking in the study of post-traumatic osteoarthritis (PTOA) is
overviewed: the osteoarthritis which follows acute joint injury. The review particularly …

Investigation of TSG-6 as a Potential Biomarker and Therapeutic Target in Osteoarthritis

Y Dong - 2020 - search.proquest.com
Osteoarthritis (OA) is a major global health problem, where pain and loss of mobility in
synovial joints lead to reduced quality of life. However, the aetiology of OA is incompletely …

[引用][C] Wechselwirkung der Kollagen-Induzierten Arthritis und der Parodontitis im Mausmodell

AL Buschhart - 2020 - Dissertation, Rostock, Universität …